MedTrace Logo

Bed Rest for Idiopathic Sudden Sensorineural Hearing Loss

NCT00416143 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2006-12-27

No results posted yet for this study

Summary

sudden sensorineural hearing loss:

* idiopathic in most cases
* 5-20/100,000 new cases annually in the U.S
* no establishes pathogenesis
* treated with oral steroids in most cases
* \~50% improvement in hearing levels
* bed rest - acceptable treatment, not well investigated

Conditions

  • Sudden Loss of Hearing

Interventions

PROCEDURE

bed rest

DRUG

prednisone - oral corticosteroid 1mg/kg/D for 1 week

Sponsors & Collaborators

  • Sheba Medical Center

    lead OTHER_GOV

Principal Investigators

  • Eldar Carmel, MD · Sheba Medical Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-06-30
Completion
2008-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00416143 on ClinicalTrials.gov